CompletedNot Applicable

Assessing Uterine Ultrasound Done as a Diagnostic Tool for the Depth of Carcinoma Invasion

Israel20 participantsStarted 2015-03

Plain-language summary

In this study the investigators aim to assess the diagnostic performance of intraoperative, ultrasonographic assessment of the surgical extracted uterus for determining myometrial invasion's depth in comparison to preoperative ultrasound, intraoperative gross inspection and final pathological report (gold standard). The investigators hope that intraoperative gross inspection of the extracted uterus might offer an additional intraoperative tool for assessing the need for pelvic lymphadenectomy in early stage of endometrial cancer at least as good as pathological exam.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient's age is 18 or above
✓. Patient has been scheduled to undergo hysterectomy (laparoscopic or abdominal) for the staging and treatment of endometrial cancer (endometrioid subtype) and with the relevant suspected symptoms.
✓. Patient able to understand,read and sign informed consent.
✓. Patient is not participating in other medical trials at present or in the past 30 days

Exclusion criteria

✕. Age under 18 years
✕. Patients assessed preoperatively to be at stage 2 and higher endometrial carcinoma
✕. Subjects which their biopsy in the pre operating process will include high risk cell types:

What they're measuring

Tumor invasion

Timeframe: Average of 2 weeks (immediate assessment by ultrasound, average of 2 weeks for final pathological report)

Trial details

NCT IDNCT02407535

SponsorCarmel Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-06-01

View on ClinicalTrials.gov More Endometrial Endometroid Carcinoma trials